GeneIQ is a high-volume molecular diagnostics laboratory based in Dallas, Texas. Our state-of-the-art laboratory services long-term care facilities, physician practices, state and local governments, corporate return-to-work programs, and many organizations throughout the United States.
At the core of GeneIQ lies the latest innovations in Pharmacogenomics, the science of determining how genetic variability influences physiological responses to drugs, from absorption and metabolism to pharmacologic action and therapeutic effect.
That’s why we built our laboratory and teams to harness the power of DNA and deliver intelligent solutions tailored for the individual. Precision medicine is based on individual DNA, not a “one size fits all” approach.
We have also created a highly efficient, automated lab process with a paperless, web-based system that provides 24-hour turnaround of results after receipt of the specimen. Our support and management teams are passionate about providing the highest level of service to our clients.
GenelQ utilizes real-time reverse transcriptase polymerase chain reaction (RT-PCR) testing. Our COVID-19 testing methodology includes several assays that have received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). These include the Lyra Direct Dry Swab assay from Quidel and the TaqPath COVID-19 Multiplex assay from ThermoFisher Scientific. By diversifying our COVID-19 assay portfolio, we have a steady supply of reagents and consumables to fulfill the demand for testing. We use leading ThermoFisher PCR With leading-edge instrumentation, which includesing the QuantStudio 7Pro and the , QuantStudio 12K Flex instruments, and more, we can process several assays, including Lyra Direct Dry Swab from Quidel, TaqPath COVID-19 Multiplex from ThermoFisher Scientific, and others. In addition, our unique method for viral RNA extraction is fast and efficient, further increasing our capacity for throughput while minimizing dependence on the short supply of plastic consumables.
Sample Collection Methodology
The GeneIQ sample collection methodology from Quidel employs a non-invasive, anterior nasal swab, which is inserted into the shallow portion of the nasal cavity. It is rotated four times along the anterior membrane of each nostril, and then placed in a collection tube for transport to the lab. Our physician-directed, self-administered sample collection method is as effective as the physician-administered nasopharyngeal swab, but without the discomfort.
Smarter Service, At GeneIQ, we pride ourselves on providing high-touch, comprehensive customer service for supporting local and national clients. You can trust our team to provide exemplary customer service for your organization. We are always available to help streamline processes and provide a personalized solution. Our onboarding process, internet-based training and video conferencing-combined with our dedicated account management-ensure a smooth implementation of our testing program.
These capabilities enable us to effectively deal with any logistical complexities that may arise. This is particularly important when serving clients with multiple collection points throughout a state or nationwide. For clients that require a high density of testing, GeneIQ can provide a mobile courier service to pick-up specimens and transport specimens to our laboratory for PCR testing.
Test results are provided to the designated client coordinator via a Health Insurance Portability and Accountability Act (HIPAA)-compliant portal, as well as to the appropriate Centers for Disease Control and Prevention (CDC) office and, state and local health administrative agencies.